Management of Spinal Emergencies in Patients on Direct Oral Anticoagulants.
Acute Disease
Aged
Aged, 80 and over
Anticoagulants
/ adverse effects
Antithrombins
/ adverse effects
Blood Coagulation Factors
/ therapeutic use
Blood Loss, Surgical
/ prevention & control
Decompression, Surgical
/ methods
Emergencies
Factor Xa Inhibitors
/ adverse effects
Female
Hematoma, Subdural, Spinal
/ complications
Hemostatics
/ therapeutic use
Humans
Male
Middle Aged
Perimeningeal Infections
/ complications
Platelet Transfusion
Retrospective Studies
Spinal Cord Compression
/ etiology
Spinal Fractures
/ complications
Spinal Neoplasms
/ complications
Spinal Stenosis
/ complications
Tranexamic Acid
/ therapeutic use
Anticoagulants
Hemorrhage
Hemostasis
Spine
Journal
World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
12
05
2019
revised:
30
07
2019
accepted:
31
07
2019
pubmed:
11
8
2019
medline:
28
1
2020
entrez:
11
8
2019
Statut:
ppublish
Résumé
Spine surgeons increasingly encounter acute spinal pathologies in patients treated with direct oral anticoagulants (DOACs), but only limited data on the management of these patients are currently available. We retrospectively analyzed patients who presented to our department with acute spinal pathology during treatment with DOAC and who required urgent surgical therapy. Patient characteristics and treatment modalities were studied, with specific focus on the management of hemostasis and surgical therapy. Furthermore, we analyzed 19 cases of spinal emergencies during DOAC treatment reported in the literature. A total of 12 patients were identified and included in the present analysis. Patients suffered from acute spinal cord compression caused by spinal tumor manifestation (n = 5), empyema (n = 4), degenerative spinal stenosis (n = 1), hematoma (n = 1), and vertebral body fracture/dislocation (n = 2). All patients underwent emergency surgical treatment. Prohemostatic substances were administered perioperatively in 10 patients (83%) and included administration of prothrombin complex concentrates (83%), tranexamic acid (17%), and transfusion of platelets (8%). A total of 9 patients (75%) showed postoperative improvement of neurologic symptoms, and the in-hospital mortality in this patient cohort was 17%. Emergency spine surgery is feasible and should be considered in patients on treatment with DOAC. The (low) risk of intraoperative bleeding complications has to be weighed against the risk of permanent disability if surgical decompression is delayed. Administration of prothrombin complex concentrates and tranexamic acid may improve the coagulation before surgery, especially in cases of unavailable specific antidotes.
Identifiants
pubmed: 31400524
pii: S1878-8750(19)32150-3
doi: 10.1016/j.wneu.2019.07.234
pii:
doi:
Substances chimiques
Anticoagulants
0
Antithrombins
0
Blood Coagulation Factors
0
Factor Xa Inhibitors
0
Hemostatics
0
prothrombin complex concentrates
37224-63-8
Tranexamic Acid
6T84R30KC1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e570-e578Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.